EDWARD FRUITMAN: Open Payments
NPI 1558434134 · HEWLETT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$101,302 in 256 payments from 14 companies in 2025. Trend: 2023 $96,574 · 2024 $42,008 · 2025 $101,302
Speaker / faculty: $86,731Food & beverage: $6,121Consulting: $6,000Travel & lodging: $2,250Education: $201
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 54 | $33,176 |
| E.R. Squibb & Sons, L.L.C. | 58 | $26,776 |
| ABBVIE INC. | 55 | $22,695 |
| Neurocrine BioSciences, Inc. | 29 | $17,556 |
| Axsome Therapeutics, Inc. | 28 | $406 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $252 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $103 |
| Alkermes, Inc. | 4 | $76 |
| Bausch Health US, LLC | 4 | $63 |
| Corium, LLC | 3 | $51 |
Products named: UZEDY, COBENFY, VRAYLAR, INGREZZA, Auvelity, CAPLYTA, BOTOX, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
